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Endothelial progenitor cells (EPCs) are mobilized from either bone marrow or 
arterial walls to restore blood perfusion to ischemic organs and establish the vascu-
lar network within growing tumors [1]. The Ca2+ machinery plays a key role in EPC 
activation and might serve a molecular target for novel therapies of highly angiogen-
ic tumors, such as renal cell carcinoma (RCC) [1]. The Ca2+ toolkit is remodelled in 
EPCs isolated from RCC patients (RCC-EPCs) as respect to healthy donors [2]. The 
present study was undertaken to evaluate for the first time the functional properties 
of EPCs isolated from tumor patients by focusing on RCC-EPCs. We extended our 
analysis at microscopic level by monitoring the sub-cellular structure of RCC-EPCs 
relative to their Ca2+ signalling fingerprint. Our results showed a striking function-
al and ultrastructural difference between RCC-EPCs and their normal counterparts, 
which might be the basis for designing novel, more specific anti-angiogenic treat-
ments.
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